These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 1978371
21. Comparison of withdrawal of buspirone and diazepam: a placebo controlled study. Fontaine R, Beaudry P, Beauclair L, Chouinard G. Prog Neuropsychopharmacol Biol Psychiatry; 1987; 11(2-3):189-97. PubMed ID: 2888159 [Abstract] [Full Text] [Related]
22. Anxiolytic efficacy and safety of ketazolam compared with diazepam and placebo. Kim KK, Sirman A, Trainor FS, Lee BY. Clin Ther; 1980; 3(1):9-14. PubMed ID: 6105920 [Abstract] [Full Text] [Related]
28. A comparison of prazepam, diazepam, lorazepam and placebo in anxious outpatients in non-psychiatric private practices. Zung WW, Daniel JT, King RE, Moore DT. J Clin Psychiatry; 1981 Jul; 42(7):280-4. PubMed ID: 6113234 [Abstract] [Full Text] [Related]
29. A therapeutic and discontinuation study of clobazam and diazepam in anxiety neurosis. Lapierre YD, Tremblay A, Gagnon A, Monpremier P, Berliss H, Oyewumi LK. J Clin Psychiatry; 1982 Sep; 43(9):372-4. PubMed ID: 6126475 [Abstract] [Full Text] [Related]
30. Effect of clorazepate on depressed mood in anxious patients. Zung WW. J Clin Psychiatry; 1987 Jan; 48(1):13-4. PubMed ID: 2879832 [Abstract] [Full Text] [Related]
31. Ipsapirone: evidence for efficacy in depression. Heller AH, Beneke M, Kuemmel B, Spencer D, Kurtz NM. Psychopharmacol Bull; 1990 Jan; 26(2):219-22. PubMed ID: 1978372 [Abstract] [Full Text] [Related]
32. Comparison of buspirone in two separate studies. Goldberg HL, Finnerty R. J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):87-91. PubMed ID: 6759499 [Abstract] [Full Text] [Related]
33. Gepirone in anxiety: a pilot study. Csanalosi I, Schweizer E, Case WG, Rickels K. J Clin Psychopharmacol; 1987 Feb; 7(1):31-3. PubMed ID: 2880873 [Abstract] [Full Text] [Related]
34. The side effect profile of buspirone in comparison to active controls and placebo. Newton RE, Casten GP, Alms DR, Benes CO, Marunycz JD. J Clin Psychiatry; 1982 Dec; 43(12 Pt 2):100-2. PubMed ID: 6130065 [Abstract] [Full Text] [Related]
35. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder. Ballenger JC, McDonald S, Noyes R, Rickels K, Woods SW, Patin J, Lydiard B, Garvey M, Cook B, Goodard AW. Adv Biochem Psychopharmacol; 1992 Dec; 47():431-47. PubMed ID: 1354920 [No Abstract] [Full Text] [Related]
37. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group. Lydiard RB, Ballenger JC, Rickels K. J Clin Psychiatry; 1997 Jun; 58 Suppl 11():11-8. PubMed ID: 9363043 [Abstract] [Full Text] [Related]
39. Controlled comparison of the efficacy and safety of four doses of suriclone, diazepam, and placebo in generalized anxiety disorder. Ansseau M, Olié JP, von Frenckell R, Jourdain G, Stehle B, Guillet P. Psychopharmacology (Berl); 1991 Jun; 104(4):439-43. PubMed ID: 1685793 [Abstract] [Full Text] [Related]